Rosetta Genomics (ROSG) Closes 5.5M Offering at $5/Share

Rosetta Genomics Ltd. (Nasdaq: ROSG), announced the closing of an underwritten public offering of 5,500,000 ordinary shares at an offering price of $5.00 per share. The gross proceeds to Rosetta were $27.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Rosetta. In addition, Rosetta has granted the underwriter a 45-day option to purchase up to 825,000 additional ordinary shares to cover over-allotments, if any.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Denarius Metals acquires 15% stake in Copper Giant, Trafigura invests
• Aptevo Therapeutics files prospectus for resale of 6.4M shares
• Lazard Global Total Return fund declares $0.1534 monthly distribution